<VariationArchive RecordType="classified" VariationID="31577" VariationName="NM_173477.5(USH1G):c.163_164+13del" VariationType="Deletion" Accession="VCV000031577" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-03" DateCreated="2021-03-12" MostRecentSubmission="2021-03-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="40256" VariationID="31577">
      <GeneList>
        <Gene Symbol="USH1G" FullName="USH1 protein network component sans" GeneID="124590" HGNC_ID="HGNC:16356" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="74916083" stop="74923255" display_start="74916083" display_stop="74923255" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="72912175" stop="72919350" display_start="72912175" display_stop="72919350" Strand="-" />
          </Location>
          <OMIM>607696</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_173477.5(USH1G):c.163_164+13del</Name>
      <CanonicalSPDI>NC_000017.11:74922896:GGGGCGTACTCACCCG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="74922897" stop="74922911" display_start="74922897" display_stop="74922911" variantLength="15" positionVCF="74922896" referenceAlleleVCF="TGGGGCGTACTCACCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="72918992" stop="72919006" display_start="72918992" display_stop="72919006" variantLength="15" positionVCF="72918991" referenceAlleleVCF="TGGGGCGTACTCACCC" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.72918993_72919007del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.72918993_72919007del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.74922898_74922912del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.74922898_74922912del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007882.2" sequenceAccession="NG_007882" sequenceVersion="2" change="g.5353_5367del">
            <Expression>NG_007882.2:g.5353_5367del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033062.2" sequenceAccession="NG_033062" sequenceVersion="2" change="g.3624_3638del">
            <Expression>NG_033062.2:g.3624_3638del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282489.3" sequenceAccession="NM_001282489" sequenceVersion="3" change="c.-94_-93+13del">
            <Expression>NM_001282489.3:c.-94_-93+13del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173477.5" sequenceAccession="NM_173477" sequenceVersion="5" change="c.163_164+13del" MANESelect="true">
            <Expression>NM_173477.5:c.163_164+13del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1416" sequenceAccession="LRG_1416">
            <Expression>LRG_1416:g.5353_5367del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1416t1" sequenceAccession="LRG_1416t1">
            <Expression>LRG_1416t1:c.163_164+13del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="607696.0006" DB="OMIM" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_173477.5(USH1G):c.163_164+13del AND Usher syndrome type 1G" Accession="RCV000024283" Version="5">
        <ClassifiedConditionList TraitSetID="741">
          <ClassifiedCondition DB="MedGen" ID="C1847089">Usher syndrome type 1G</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-03-12" MostRecentSubmission="2021-03-12">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21044053</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="741" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3938" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">USHER SYNDROME, TYPE IG, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="607696.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 1G</ElementValue>
                <XRef ID="MONDO:0011748" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH1G</ElementValue>
                <XRef Type="MIM" ID="606943" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type I (USH1) is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa (RP). Unless fitted with a cochlear implant, individuals do not typically develop speech. RP, a progressive, bilateral, symmetric degeneration of rod and cone functions of the retina, develops in adolescence, resulting in progressively constricted visual fields and impaired visual acuity.</Attribute>
                <XRef ID="NBK1265" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301442</ID>
                <ID Source="BookShelf">NBK1265</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21697857</ID>
              </Citation>
              <XRef ID="231169" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C1847089" DB="MedGen" />
              <XRef ID="MONDO:0011748" DB="MONDO" />
              <XRef Type="MIM" ID="606943" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50838" SubmissionDate="2021-03-09" DateLastUpdated="2021-03-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607696.0006_USHER SYNDROME, TYPE IG, MILD" title="USH1G, 15-BP DEL, NT163_USHER SYNDROME, TYPE IG, MILD" />
        <ClinVarAccession Accession="SCV000045574" DateUpdated="2021-03-12" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected members of a consanguineous Pakistani family with Usher syndrome type IG (USH1G; 606943), Bashir et al. (2010) identified a homozygous 15-bp deletion (163_164+13del15) involving nucleotides in the first exon and intron of the USH1G gene. The mutation was not found in 200 control chromosomes. Investigation of the effect of the mutation was hampered because RNA from patient blood did not show sufficient expression of SANS. In silico analysis predicted that retention of the first intron in the RNA resulting from the mutation would introduce a frameshift and premature termination, which could result in nonsense-mediated mRNA decay. However, if the mRNA is processed, the frameshift would result in a truncated nonfunctional protein of 58 amino acids. The patients had an atypical form of Usher syndrome, with moderate to severe hearing loss, normal vestibular function, and lack of eyesight problems. However, funduscopy showed mild symptoms of retinitis pigmentosa and pale optic discs in 3 of the older affected patients at ages 13, 15, and 22 years, respectively. The findings indicated that even a truncating mutation in the USH1G gene can result in a relatively mild phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">21044053</ID>
              </Citation>
              <XRef DB="OMIM" ID="606943" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH1G" />
          </GeneList>
          <Name>USH1G, 15-BP DEL, NT163</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15-BP DEL, NT163</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607696.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">USHER SYNDROME, TYPE IG, MILD</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50838" TraitType="Disease" MappingType="Name" MappingValue="USHER SYNDROME, TYPE IG, MILD" MappingRef="Preferred">
        <MedGen CUI="C1847089" Name="Usher syndrome type 1G" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

